Showing results (581-590 of 3,750) with videos related to
Sort By:
Pageof 375
Menopause (New York, N.Y.)|November 2, 2010
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal womenMargaret J Nachtigall, Rebecca H Jessel, Robert Flaumenhaft, et al.Menopause (New York, N.Y.)|September 24, 2010
Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level?Anne M van Altena, Hilda Holtsema, Jan C Hendriks, et al.Menopause (New York, N.Y.)|November 6, 2010
Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohortsAgnès Fournier, Céline Kernaleguen, Henri Panjo, et al.Menopause (New York, N.Y.)|April 4, 2013
More vasomotor symptoms in menopause among women with a history of hypertensive pregnancy diseases compared with women with normotensive pregnanciesJosé T Drost, Yvonne T van der Schouw, Gerrie-Cor M Herber-Gast, et al.Menopause (New York, N.Y.)|March 14, 2013
Hyperresistinemia is associated with postmenopausal breast cancerMaria Dalamaga, Konstantinos Karmaniolas, Evangelia Papadavid, et al.Menopause (New York, N.Y.)|March 14, 2013
Classifying menopause stage by menstrual calendars and annual interviews: need for improved questionnairesPangaja Paramsothy, Siobán D Harlow, Michael R Elliott, et al.Menopause (New York, N.Y.)|February 14, 2013
Comparative study of the quality of life associated with menopause in Tunisia and FranceFarida Ferrand, Selma Hajri, Sarah Benzineb, et al.Menopause (New York, N.Y.)|February 21, 2013
Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trialAlexander M Quaas, Naoko Kono, Wendy J Mack, et al.Menopause (New York, N.Y.)|May 2, 2013
Relationship between objectively recorded hot flashes and sleep disturbances among breast cancer patients: investigating hot flash characteristics other than frequencyMarie-Hélène Savard, Josée Savard, Aude Caplette-Gingras, et al.Menopause (New York, N.Y.)|May 2, 2013
Adverse association between obesity and menopause in mice treated with bezafibrate, a pan peroxisome proliferator-activated receptor agonistTatiane da Silva Faria, Antonio Ludgero Correia, Thabata Lessa dos Anjos, et al.Pageof 375